Serum 25-Hydroxyvitamin D, Non-Alcoholic Fatty Liver Disease and Type 2 Diabetes

Serum 25-Hydroxyvitamin D, Non-Alcoholic Fatty Liver Disease and Type 2 Diabetes Publisher Pubmed

Afarideh M¹ ; Ghajar A¹ ; Noshad S¹ ; Saadat M¹ ; Khajeh E¹ ; Esteghamati A¹

Show Affiliations

1. Endocrinology and Metabolism Research Center (EMRC), Vali-Asr Hospital, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran

Source: Nutrition# Metabolism and Cardiovascular Diseases Published:2017

Abstract

[No abstract available]

2. Associations of Serum S100b and S100p With the Presence and Classification of Diabetic Peripheral Neuropathy in Adults With Type 2 Diabetes: A Case-Cohort Study, Canadian Journal of Diabetes (2019)

3. Baseline High-Sensitivity C-Reactive Protein Predicts Macrovascular and Microvascular Complications of Type 2 Diabetes: A Population-Based Study, Annals of Nutrition and Metabolism (2018)

4. Diabetes in Iran: Prospective Analysis From First Nationwide Diabetes Report of National Program for Prevention and Control of Diabetes (Nppcd-2016), Scientific Reports (2017)

5. Family History of Diabetes and the Risk of Coronary Heart Disease in People With or Without Type 2 Diabetes, Diabetes and Metabolism (2017)

6. Complex Association of Serum Alanine Aminotransferase With the Risk of Future Cardiovascular Disease in Type 2 Diabetes, Atherosclerosis (2016)

7. Fasting Hyperinsulinaemia and 2-H Glycaemia Predict Coronary Heart Disease in Patients With Type 2 Diabetes, Diabetes and Metabolism (2016)

Experts (# of related papers)

View all Related Experts

Alireza Esteghamati (7)

Abbas Tafakhori (1)

Style	Citing Format
MLA	Afarideh M, et al.. "Serum 25-Hydroxyvitamin D, Non-Alcoholic Fatty Liver Disease and Type 2 Diabetes." Nutrition# Metabolism and Cardiovascular Diseases, vol. 27, no. 1, 2017, pp. 93-95.
APA	Afarideh M, Ghajar A, Noshad S, Saadat M, Khajeh E, Esteghamati A (2017). Serum 25-Hydroxyvitamin D, Non-Alcoholic Fatty Liver Disease and Type 2 Diabetes. Nutrition# Metabolism and Cardiovascular Diseases, 27(1), 93-95.
Chicago	Afarideh M, Ghajar A, Noshad S, Saadat M, Khajeh E, Esteghamati A. "Serum 25-Hydroxyvitamin D, Non-Alcoholic Fatty Liver Disease and Type 2 Diabetes." Nutrition# Metabolism and Cardiovascular Diseases 27, no. 1 (2017): 93-95.
Harvard	Afarideh M et al. (2017) 'Serum 25-Hydroxyvitamin D, Non-Alcoholic Fatty Liver Disease and Type 2 Diabetes', Nutrition# Metabolism and Cardiovascular Diseases, 27(1), pp. 93-95.
Vancouver	Afarideh M, Ghajar A, Noshad S, Saadat M, Khajeh E, Esteghamati A. Serum 25-Hydroxyvitamin D, Non-Alcoholic Fatty Liver Disease and Type 2 Diabetes. Nutrition# Metabolism and Cardiovascular Diseases. 2017;27(1):93-95.
BibTex	@article{ author = {Afarideh M and Ghajar A and Noshad S and Saadat M and Khajeh E and Esteghamati A}, title = {Serum 25-Hydroxyvitamin D, Non-Alcoholic Fatty Liver Disease and Type 2 Diabetes}, journal = {Nutrition# Metabolism and Cardiovascular Diseases}, volume = {27}, number = {1}, pages = {93-95}, year = {2017} }
RIS	TY - JOUR AU - Afarideh M AU - Ghajar A AU - Noshad S AU - Saadat M AU - Khajeh E AU - Esteghamati A TI - Serum 25-Hydroxyvitamin D, Non-Alcoholic Fatty Liver Disease and Type 2 Diabetes JO - Nutrition# Metabolism and Cardiovascular Diseases VL - 27 IS - 1 SP - 93 EP - 95 PY - 2017 ER -

Science Communicator Platform

Authors

Authors Affiliations

Abstract